The Iceland-based DeCode Genetics team found genetic variants linked to a high risk of developing exfoliation glaucoma, a form of the disease that does not respond well to treatment. In their genome-wide association study, Kari Stefansson and his team found that changes to exon 1 of the LOXL1 gene on chromosome 15q24.1 were associated with exfoliation glaucoma.